The number of patients with oncological diseases is increasing continuously in all over the world. It holds second place after cardiovascular diseases by its morbidity and mortality.
The most common methods of treatment for cancer are surgery, radiation therapy and chemotherapy. Through this approach, it becomes a real the victory over this disease.
The Department of Chemotherapy recently had been created at Erebouni MC under the management of Dr. Haykuhi Gekchyan-Kzhdryan (MD, PhD, Chief chemotherapist at MH RA)
The department carried out the chemotherapy and target-therapy in accordance with the guidelines and evidence-based medicine (ESMO, NCCN). The diagnostics is performed on the base on endoscopy, radiation, radiology, immuno-histo-chemical and genetic tests, as well as biopsies and others. Particularly important place holds the accompanying therapeutic measures that focused on prevention, mitigation and treatment of complications arising as side effect of conducted chemotherapy.
Chemotherapy is carried out by infusion pumps, regulating the amount and speed of administered drug. In case of necessity for long-term therapy course a port-a-cath is placed. This gives access to the central venous system and the ability to distribute the drug throughout the body without repeated peripheral intravenous injection.
In Department of Oncology, technological innovation Paxman Scalp Cooling system has been successfully used. Frozen liquid silicone gel freezes the scalp during chemotherapy and prevents 70-80% of hair loss.
Chemotherapy medicine are dissolving in the liquid and preparing for injection in the special handling room, which provided with all necessary conditions: the sterility and the air cleaning tools.
The Department of Chemotherapy is carried out for the treatment of patients with solid tumors of:
• CNS
• maxillofacial region
• breast
• respiration system
• gastrointestinal tract
• urinary-genital system
• bone
• neuroendocrine systems
• soft tissue
• melanomas
• gynecological oncologic diseases
Tactics and strategy of treating of oncological diseases defined in line with modern European and American protocols.
